https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256545
The Journal of Allergy and Clinical Immunology; Liu J, Zheng X et. al.
Jun 2nd, 2020 - Successful use of methylprednisolone for treating severe COVID-19.|2020|Liu J,Zheng X,Huang Y,Shan H,Huang J,|therapeutic use,immunology,pathogenicity,diagnosis,drug therapy,immunology,physiopathology,diagnosis,immunology,physiopathology,prevention & control,therapeutic use,diagnosis,drug therapy,immunology,physiopathology,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255259
International Journal of Infectious Diseases : IJID : Off... Wang Q, Hu Z
May 30th, 2020 - COVID-19 associated cytokine storm could rapidly induce ARDS, and the patients would require mechanical ventilation. However, the prognosis was not that optimistic. The outcome might be changed if the timely intervention of EBP was performed. We present a case of severe SARS-CoV-2 infection who recovered from a cytokine storm.
https://www.sciencedirect.com/science/article/pii/S0168010220303990
Coronaviruses (CoVs) are large positive stranded enveloped RNA viruses that generally cause enteric and respiratory diseases in humans and in animals. Most human CoVs have recently attracted global attention to their lethal potential and great infectious capacity. A highly pathogenic CoV, called COVID-19 or SARS‐CoV2, dramatically emerged in December 2019 in Wuhan, China. T...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196837
Proceedings of the National Academy of Sciences of the Un... Duan K, Liu B et. al.
Apr 8th, 2020 - Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360507
Cardiorenal Medicine; Iannaccone G, Scacciavillani R et. al.
Jul 1st, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged in Wuhan, Hubei-China, as responsible for the coronavirus disease 2019 (COVID-19) and then spread rapidly worldwide. While most individuals remain asymptomatic or develop only mild symptoms, approximately 5% develop severe forms of COVID-19 characterized by acute respiratory distress...
https://www.neurores.org/index.php/neurores/article/view/602/580
Coronavirus (CoV) is a virus infectious disease with a considerable spectrum of clinical presentations. Symptoms ranged from asymptomatic infection to severe pneumonia that may lead to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and several clinical complications. Neurologic symptoms related to CoV have been described recently in the literature. The relationship between SARS-Co...
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8447011/
Journal of Cardiac Surgery; Actis Dato GM.
Sep 15th, 2021 - Infections and pandemics will condition us in an increasingly predominant way regarding diagnostic, medical, and surgical activities in all specialist areas. Particularly cardiovascular disease represents an important field also during other health crisis like COV19 pandemia. A common strategy in the future, to cohabit with pandemic events and to be able to continue an elective and not only eme...
https://journals.sagepub.com/doi/full/10.1177/2050313X20933473
The COVID-19 pandemic has brought about an urgent need for effective treatment, while conserving vital resources such as intensive care unit beds and ventilators. Antivirals, convalescent plasma, and biologics have been used with mixed results. The profound “cytokine storm” induced endotheliopathy and microthrombotic disease in patients with COVID-19 may lead to acut...
https://doi.org/10.1056/NEJMe2203329
The New England Journal of Medicine; Offit PA
Apr 14th, 2022 - Covid-19 Boosters - Where from Here?|2022|Offit PA,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445369
Neuroepidemiology Beghi E, Feigin V et. al.
Jul 2nd, 2020 - The present outbreak caused by SARS-CoV-2, an influenza virus with neurotropic potential, presents with neurological manifestations in a large proportion of the affected individuals. Disorders of the central and peripheral nervous system are all present, while stroke, ataxia, seizures, and depressed level of consciousness are more common in severely affected patients. People with these severe c...
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/728792
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to the Philippines.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/715496
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Haiti.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/715503
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Bangladesh.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/715321
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Taiwan.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/697708
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Taiwan.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/687494
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Nepal.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/660877
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Namibia.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/660878
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Mozambique.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/660879
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Cameroon.
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/660882
Make sure you are vaccinated and up to date with your COVID-19 vaccines before traveling to Mali.
